associated with 3 TC and famciclovir administration are replication defective. Hepalology 1998; 27:628-33. 11. Atkins M. Hunt CM, Brown N, Gray F, Sanathanan. L, Woessner M, et al. Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients. Hepatology 1998;28:319A and in press. 12. SchiffE. Lamivudine for hepatitis B in clinical practice. J Med Virol (in press).
www.medicusamicus.com medi.ru |